| bioMérieux S.A.. (3/3/17). "Press Release: 2016 Financial Results". |
2017-03-03 |
| Sofinnova Partners. (3/2/17). "Press Release: Sofinnova Partners Raises €106 million in a First Closing of Its Industrial Biotech Fund". Paris. |
2017-03-02 |
| Cerenis Therapeutics S.A.. (3/1/17). "Press Release: Cerenis Therapeutics Announces Top Line Results of CARAT Phase II Study. No Statistical Difference Observed between CER-001 and Placebo". Toulouse & Ann Arbor, MI. |
2017-03-01 |
| Nicox S.A.. (3/1/17). "Press Release: Nicox to Participate at Two Upcoming Investor Conferences". Sophia Antipolis. |
2017-03-01 |
| Genticel S.A.. (2/28/17). "Press Release: Genticel becomes “Genkyotex”. Genticel’s General Meeting Approves the Strategic Combination with GenKyoTex SA [Not for Australia, Canada, Japan, New Zealand, South Africa or the United States]". Toulouse & Geneva |
2017-02-28 |
| Genticel S.A.. (2/28/17). "Press Release: Genticel Announces Its 2016 Annual Results". Paris & Toulouse. |
2017-02-28 |
| Sanofi S.A.. (2/27/17). "Press Release: Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility". Paris & Basel. |
2017-02-27 |
| bioMérieux S.A.. (2/24/17). "Press Release: bioMérieux’s VIDAS B•R•A•H•M•S PCT Becomes the First FDA-cleared Procalcitonin Assay as an Aid for Antibiotic Stewardship in Respiratory Infections and Sepsis". |
2017-02-24 |
| Valneva S.E.. (2/23/17). "Press Release: Valneva Reports Strong Q4 and FY 2016 Business Performance, Expects Further Growth in Sales and EBITDA, R&D Progress in 2017". Lyon. |
2017-02-23 |
| Ipsen S.A.. (2/23/17). "Press Release: Ipsen Delivers Strong 2016 Results and Expects Further Sales Growth and Margin Enhancement for 2017". Paris. |
2017-02-23 |
| TxCell S.A.. (2/22/17). "Press Release: TxCell Successfully Completes a €11 Million Capital Increase [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan]". Valbonne. |
2017-02-22 |
| Neovacs S.A.. (2/21/17). "Press Release: Neovacs and BioSense Sign Option Agreement Worth up to €65 Million plus Royalties for Chinese Development and Commercial Rights to IFNalpha Kinoid for Lupus and Dermatomyositis". Paris. |
2017-02-21 |
| Sartorius Stedim Biotech S.A.. (2/21/17). "Press Release: Resolutions by the Board of Directors". Aubagne. |
2017-02-21 |
| Lysogene S.A.. (2/21/17). "Press Release: Lysogene Receives Orphan Drug Designation from EMA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-02-21 |
| Biophytis S.A.. (2/21/17). "Press Release: Biophytis Relocates to Pierre and Marie Curie University (UPMC) Campus and Solidifies Creation of Leading Translational Platform for Age-related Disease". Paris. |
2017-02-21 |
| Cerenis Therapeutics S.A.. (2/17/16). "Press Release: 2016 Annual Results. Solid Cash Position of €24.7 million and Finalization of CARAT Phase 2 Clinical Study". Toulouse & Ann Arbor, MI. |
2017-02-17 |
| Euronext N.V.. (2/15/17). "Press Release: Inventiva Lists on Euronext Paris. €48 Million Raised, Market Capitalisation €133 Million". Paris. |
2017-02-15 |
| Immunicum AB. (2/14/17). "Press Release: Immunicum AB Announces Approval in France for Its Clinical Trial Application for Intuvax in Metastatic Renal Cell Carcinoma". Gothenburg. |
2017-02-14 |
| Servier. (2/14/17). "Press Release: Servier and GAIA Extend Their Partnership to Provide Patients around the World with Deprexis, an Internet-based Cognitive Behavioral Therapy for Depression". Suresnes & Hamburg. |
2017-02-14 |
| Premaitha Health plc. (2/13/17). "Press Release: New Partnership with Major European Diagnostics Group". Manchester. |
2017-02-13 |
| Ipsen S.A.. (2/13/17). "Press Release: Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi". Paris. |
2017-02-13 |
| Neovacs S.A.. (2/9/17). "Press Release: Neovacs Issued New Broad Patent in China for IFNalpha Kinoid". Paris. |
2017-02-09 |
| Nicox S.A.. (2/9/17). "Press Release: Nicox to Present at the 6th Annual Leerink Partners Global Healthcare Conference". Sophia Antipolis. |
2017-02-09 |
| Euronext N.V.. (2/8/17). "Press Release: Lysogene Lists on Euronext. €22.6 Million Raised, Market Capitalisation of approximately €82 Million". Paris. |
2017-02-08 |
| Global Bioenergies S.A.. (2/7/17). "Press Release: First Production in History of Fully Renewable ETBE". Évry. |
2017-02-07 |
| Lysogene S.A.. (2/7/17). "Press Release: Lysogene Announces Its Successful IPO on Euronext Paris with nearly €22.6m Raised [Not for US, CA, AU, JP]". Paris. |
2017-02-07 |
| OSE Immunotherapeutics S.A.. (2/7/17). "Press Release: OSE Immunotherapeutics to Present Corporate Overview at Upcoming BIO CEO & Investor Conference New York February 13-14, 2017". Nantes. |
2017-02-07 |
| Pharnext S.A.. (2/7/17). "Press Release: Pharnext to Present at 2017 BIO CEO & Investor Conference". Paris. |
2017-02-07 |
| Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris. |
2017-02-03 |
| IntegraGen S.A.. (2/3/17). "Press Release: IntegraGen Announces Successful Completion of a € 3.7 Million Capital Increase". Évry. |
2017-02-03 |
| Lysogene S.A.. (2/2/17). "Press Release: Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris. |
2017-02-02 |
| Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. |
2017-01-31 |
| ElsaLys Biotech SAS. (1/30/17). "Press Release: ElsaLys Biotech Expands Its Team to Strengthen Its Strategy and the Development of Its Programs". Lyon. |
2017-01-30 |
| Sanofi S.A.. (1/30/17). "Press Release: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs". Paris. |
2017-01-30 |
| Recordati Industria Chimica e Farmaceutica S.p.A.. (1/27/17). "Press Release: Recordati Announces Marketing Approval for Cystadrops". Milan. |
2017-01-27 |
| Sensorion S.A.. (1/25/17). "Press Release: Sensorion to Receive €950,000 from Bpifrance and the Occitania Region". Montpellier. |
2017-01-25 |
| Lysogene S.A.. (1/25/17). "Press Release: Lysogene Launches Its IPO on Euronext’s Regulated Market in Paris". |
2017-01-25 |
| TxCell S.A.. (1/25/17). "Press Release: Txcell Launches a Capital Increase of around 11 Million Euros with Shareholders’ Preferential Subscription Rights [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan] |
2017-01-25 |
| Neovacs S.A.. (1/25/17). "Press Release: Neovacs Reports First Positive Immunogenicity Results for IFN alpha Kinoid in Model of Type 1 Diabetes". Paris & Boston, MA. |
2017-01-25 |
| Domain Therapeutics S.A.. (1/23/17). "Press Release: Domain Therapeutics and Merck Enter into a License and Collaboration Agreement for Development of Adenosine Receptor Antagonists in Immuno-oncology". Strasbourg. |
2017-01-23 |
| DNA Script. (1/23/17). "Press Release: DNA Script Adds Dr. Heiner Dreismann, Former CEO of Roche Molecular Diagnostics, to Board of Directors". Paris. |
2017-01-23 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA. |
2017-01-19 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile. |
2017-01-19 |
| Sanofi S.A.. (1/18/17). "Press Release: Suliqua Approved in the European Union for the Treatment of Adults with Type 2 Diabetes". Paris. |
2017-01-18 |
| Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-01-18 |
| Abivax S.A.. (1/9/17). "Press Release: Abivax to Receive €8.4 Million from Bpifrance “Invest in the Future Program” (PIA) for the Development of Innovative Antiviral Drugs". Paris. |
2017-01-09 |
| IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. |
2017-01-09 |
| McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. |
2017-01-09 |
| Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. |
2017-01-09 |
| McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. |
2017-01-06 |
| Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. |
2017-01-05 |
| Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. |
2017-01-05 |
| Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY. |
2017-01-05 |
| Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris. |
2017-01-04 |
| Pharnext S.A.. (1/4/17). "Press Release: Pharnext to Attend January Investor Conferences". Paris. |
2017-01-04 |
| Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. |
2017-01-04 |
| Cellectis S.A.. (1/3/17). "Press Release: Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN". New York, NY. |
2017-01-03 |
| Cellectis S.A.. (1/3/17). "Press Release: Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT". New York, NY. |
2017-01-03 |
| Pharnext S.A.. (1/3/17). "Press Release: Pharnext Announces the Amendment to the Liquidity Contract with French Broker Gilbert Dupont and the Annual Update on Its Liquidity Agreement". Paris. |
2017-01-03 |
| Sanofi S.A.. (1/2/17). "Press Release: Sanofi and Boehringer Ingelheim Confirm Closing of Business Swap on January 1st 2017". Paris & Ingelheim. |
2017-01-02 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 5 6 7 8 9 10 11
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
